Kyverna Therapeutics (KYTX) Share-based Compensation (2023 - 2026)
Kyverna Therapeutics (KYTX) reported Share-based Compensation of $3.51 million for Q2 2026, up 39.3% from $2.52 million a year earlier and up 10.6% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kyverna Therapeutics' Share-based Compensation came in at $12.08 million, up 27.5% year-over-year; for FY2025, it was $10.08 million, up 20.6% from FY2024.
- By year, Share-based Compensation came in at $8.36 million in FY2024 (+276.4%) and $2.22 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q1 2023.
- Year over year, Share-based Compensation has now increased in each of the last three quarters, with growth averaging 110.4% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q3 2024 (growth of 555.1%); the low point was Q3 2025 (a decline of 20.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.17 million (Q1 2026), $2.7 million (Q4 2025) and $2.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Kyverna Therapeutics | 419.91 Mn | 419.91 Mn | - | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.16 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 784,000.00 |
| Sep 30, 2023 | 521,000.00 |
| Jun 30, 2023 | 447,000.00 |
| Mar 31, 2023 | 468,000.00 |
API Access
Kyverna Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();